| Filed 2020-05-12 11:29 Tx date 2018-10-03 | $TLT
Theralase Technologies Inc. | Perraton, Matthew Thomas 4 - Director of Issuer Direct Ownership | Common Shares 11 - Acquisition or disposition carried out privately | $7,000
+20,000 vol
$0.35 each | 41,000 | |
| Filed 2020-05-12 11:21 Tx date 2018-10-03 | $TLT
Theralase Technologies Inc. | Perraton, Matthew Thomas 4 - Director of Issuer Direct Ownership | Warrants 11 - Acquisition or disposition carried out privately | $10,000
+20,000 vol
$0.50 each | 29,366 | |
| Filed 2020-05-12 11:18 Tx date 2018-10-03 | $TLT
Theralase Technologies Inc. | Perraton, Matthew Thomas 4 - Director of Issuer Direct Ownership | Common Shares 11 - Acquisition or disposition carried out privately | $-7,000
-20,000 vol
$0.35 each | | |
| Filed 2020-05-12 10:50 Tx date 2020-03-09 | $TLT
Theralase Technologies Inc. | Perraton, Matthew Thomas 4 - Director of Issuer Direct Ownership | Common Shares 10 - Acquisition or disposition in the public market | $-2,700
-10,000 vol
$0.27 each | -20,000 | |
| Filed 2020-05-12 10:49 Tx date 2020-03-02 | $TLT
Theralase Technologies Inc. | Perraton, Matthew Thomas 4 - Director of Issuer Direct Ownership | Common Shares 10 - Acquisition or disposition in the public market | $-3,780
-14,000 vol
$0.27 each | -10,000 | |
| Filed 2020-05-12 10:48 Tx date 2020-02-26 | $TLT
Theralase Technologies Inc. | Perraton, Matthew Thomas 4 - Director of Issuer Direct Ownership | Common Shares 10 - Acquisition or disposition in the public market | $-580.00
-2,000 vol
$0.29 each | 4,000 | |
| Filed 2020-05-12 10:46 Tx date 2020-01-29 | $TLT
Theralase Technologies Inc. | Perraton, Matthew Thomas 4 - Director of Issuer Direct Ownership | Common Shares 10 - Acquisition or disposition in the public market | $-4,350
-15,000 vol
$0.29 each | 6,000 |